5 years ago

Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping

Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping
Fatemeh Zeinali, Christina Vrettou, Zahra Shahsavari, Hans Kristian Ploos van Amstel, Wouter de Laat, Joanne Traeger-Synodinos, Elzo de Wit, Geert Geeven, Sima Kheradmand Kia, Evelien Kruisselbrink, Carlo Vermeulen, Gerard J. te Meerman, Melissa van Kranenburg, Rumo P.M. Jansen, Jeffrey M. Beekman, Theodora Katsila, Erik Splinter, George P. Patrinos, Hossein Najmabadi, Marjon J.A.M. Verstegen, Davood Omrani, Sara L. Pulit, Ewart de Bruijn

During pregnancy, cell-free DNA (cfDNA) in maternal blood encompasses a small percentage of cell-free fetal DNA (cffDNA), an easily accessible source for determination of fetal disease status in risk families through non-invasive procedures. In case of monogenic heritable disease, background maternal cfDNA prohibits direct observation of the maternally inherited allele. Non-invasive prenatal diagnostics (NIPD) of monogenic diseases therefore relies on parental haplotyping and statistical assessment of inherited alleles from cffDNA, techniques currently unavailable for routine clinical practice. Here, we present monogenic NIPD (MG-NIPD), which requires a blood sample from both parents, for targeted locus amplification (TLA)-based phasing of heterozygous variants selectively at a gene of interest. Capture probes-based targeted sequencing of cfDNA from the pregnant mother and a tailored statistical analysis enables predicting fetal gene inheritance. MG-NIPD was validated for 18 pregnancies, focusing on CFTR, CYP21A2, and HBB. In all cases we could predict the inherited alleles with >98% confidence, even at relatively early stages (8 weeks) of pregnancy. This prediction and the accuracy of parental haplotyping was confirmed by sequencing of fetal material obtained by parallel invasive procedures. MG-NIPD is a robust method that requires standard instrumentation and can be implemented in any clinic to provide families carrying a severe monogenic disease with a prenatal diagnostic test based on a simple blood draw.

Publisher URL: http://www.cell.com/ajhg/fulltext/S0002-9297(17)30290-2

DOI: 10.1016/j.ajhg.2017.07.012

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.